GPHL appoints Nobel Laureate Randy Schekman as chief scientist

GPHL 2019-03-20 11:07:18

GPHL on March 12th appointed Randy Schekman, the 2013 Nobel Laureate in Physiology or Medicine, as the chief scientist of both the group and its subsidiary Guangzhou General Pharmaceutical Research In

TCM industry sees a promising prospect in Guangdong and Macao: Li Chuyuan

GPHL 2021-09-18 14:29:08

GPHL (Zhuhai Hengqin) Pharmaceutical Industrial Park Co., Ltd. has been established in the TCM Science and Technology Industrial Park of Co-operation between Guangdong and Macao in Zhuhai's Hengqin.

GPHL chairman Li Chuyuan attends 2021 China International Fair for Trade in Services

GPHL 2021-09-09 17:34:19

With the theme “Awesome Service, Amazing Guangdong”, the Guangdong Theme Day activity was held by the Guangdong province on September 3rd at the Fair.

Baiyunshan reports a 53% growth in net income attributable to shareholders net of non-recurring gain

GPHL 2021-08-26 17:51:29

On August 18th, GPHL’s listed arm Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (“Baiyunshan”, SH600332, HK0874) reported outstanding financial results for the first half of 2021.

GPHL, first TCM company on Fortune Global 500 List

GPHL 2021-08-04 14:16:18

GPHL ranked 468th on the Fortune Global 500 List, becoming the first company to enter this list with TCM as its major business.

GPHL tops the list of China's Top 100 TCM Companies for 10 consecutive years

GPHL 2021-07-23 18:55:59

On July 12th the National Conference on Symbiosis of Medical and Health Industries 2021 was held in Kunming, southwest China's Yunnan Province. The lists of 2020 China’s Top 100 Pharmaceutical Compani

GPHL partners with Guangzhou Branch of China CITIC Bank and CITIC Securities

GPHL 2021-07-22 19:01:51

On July 14th, in Guangzhou, GPHL entered into a strategic cooperation framework agreement with Guangzhou Branch of China CITIC Bank and CITIC Securities.

GPHL and Merck build strategic partnership on business innovation and development in GBA

GPHL 2021-03-03 14:40:15

On March 2nd, 2021, GPHL, China's leading pharmaceutical and healthcare company, entered into a Memorandum of Understanding (MOU) to build strategic collaboration with Merck.

GPHL's awards & honours in January 2021

GPHL 2021-02-24 18:14:42

GPHL has always put into practice of its commitment of "love for the world" by assuming social responsibility, fulfilling its mission, benefiting the society and serving the people.

GPHL releases 2021 plan for corporate development

GPHL 2021-02-07 18:27:00

GPHL held its 2021 Economic Work Conference at the Baiyunshan Pharmaceutical General Factory, in which the Group reviewed its work in 2020, analysed challenges in productions.

GPHL sets up China's first one billion RMB rural revitalization fund

GPHL 2021-02-05 18:29:01

GPHL held the launching ceremony for a rural revitalization fund under the name of its beverage brand Ciningji and also realised a five-year action plan in Guangzhou.

Macao Chief Executive visits GPHL

GPHL 2021-01-15 17:00:59

On January 9th, the Chief Executive of the Macao Special Administrative Region Ho Iat-seng visited GPHL’s subsidiary Guangzhou Baiyun Mountain and Hutchison Whampoa Ltd. (BMHW).

CAE academic Wang Songling named chief scientist at GPHL

GPHL 2021-01-14 16:42:53

GPHL has had a team of top talent including 3 Nobel laureates, 21 academicians and doctors as well as nearly 100 doctoral & post-doctoral researchers.

Latest findings from Roxburgh rose research published

GPHL 2020-12-25 13:45:00

The press conference was hosted by Guangdong Laboratory for Lingnan Modern Agriculture (GLLMA) and organized by GPHL, with the guidance of the DARA.

GPHL chairman attends 2020 Guangzhou Brands Talk

GPHL 2020-12-10 14:39:19

GPHL chairman Li Chuyuan, Guangzhou Baiyunshan deputy general manager Zhang Chunbo and Wanglaoji Health deputy general manager Ye Jizeng were invited to attend this event.

Overview of GPHL's awards

GPHL 2020-12-09 18:04:22

On December 3rd, the Ministry of Industry and Information Technology announced the list of the 2020 National Technological Innovation Demonstration Enterprises.